Cargando…
Use of Budesonide in the Treatment of Microscopic Colitis
Collagenous colitis and lymphocytic colitis, the two types of microscopic colitis, cause watery diarrhea. Budesonide, a glucocorticoid medication with limited systemic availability, is commonly used to treat these illnesses. Budesonide has proven efficacy in the induction of clinical remission in bo...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003217/ https://www.ncbi.nlm.nih.gov/pubmed/20616427 http://dx.doi.org/10.4103/1319-3767.65188 |
_version_ | 1782193839194243072 |
---|---|
author | Tangri, Vikram Chande, Nilesh |
author_facet | Tangri, Vikram Chande, Nilesh |
author_sort | Tangri, Vikram |
collection | PubMed |
description | Collagenous colitis and lymphocytic colitis, the two types of microscopic colitis, cause watery diarrhea. Budesonide, a glucocorticoid medication with limited systemic availability, is commonly used to treat these illnesses. Budesonide has proven efficacy in the induction of clinical remission in both collagenous colitis and lymphocytic colitis. Budesonide is effective as a maintenance drug for patients with collagenous colitis, but has not been studied for this indication in patients with lymphocytic colitis. This drug improves quality of life in patients while causing few mild adverse events. Budesonide is an effective treatment of microscopic colitis that is safe and well tolerated. |
format | Text |
id | pubmed-3003217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-30032172010-12-23 Use of Budesonide in the Treatment of Microscopic Colitis Tangri, Vikram Chande, Nilesh Saudi J Gastroenterol In Focus Collagenous colitis and lymphocytic colitis, the two types of microscopic colitis, cause watery diarrhea. Budesonide, a glucocorticoid medication with limited systemic availability, is commonly used to treat these illnesses. Budesonide has proven efficacy in the induction of clinical remission in both collagenous colitis and lymphocytic colitis. Budesonide is effective as a maintenance drug for patients with collagenous colitis, but has not been studied for this indication in patients with lymphocytic colitis. This drug improves quality of life in patients while causing few mild adverse events. Budesonide is an effective treatment of microscopic colitis that is safe and well tolerated. Medknow Publications 2010-07 /pmc/articles/PMC3003217/ /pubmed/20616427 http://dx.doi.org/10.4103/1319-3767.65188 Text en © The Saudi Journal of Gastroenterology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | In Focus Tangri, Vikram Chande, Nilesh Use of Budesonide in the Treatment of Microscopic Colitis |
title | Use of Budesonide in the Treatment of Microscopic Colitis |
title_full | Use of Budesonide in the Treatment of Microscopic Colitis |
title_fullStr | Use of Budesonide in the Treatment of Microscopic Colitis |
title_full_unstemmed | Use of Budesonide in the Treatment of Microscopic Colitis |
title_short | Use of Budesonide in the Treatment of Microscopic Colitis |
title_sort | use of budesonide in the treatment of microscopic colitis |
topic | In Focus |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003217/ https://www.ncbi.nlm.nih.gov/pubmed/20616427 http://dx.doi.org/10.4103/1319-3767.65188 |
work_keys_str_mv | AT tangrivikram useofbudesonideinthetreatmentofmicroscopiccolitis AT chandenilesh useofbudesonideinthetreatmentofmicroscopiccolitis |